Weigh Thrombolytic Pros and Cons for Submassive Pulmonary Embolism
We're getting questions about using SYSTEMIC thrombolytics to treat "submassive," or intermediate-risk, pulmonary embolism (PE).
We know to give a systemic thrombolytic for most hemodynamically unstable, or "massive," PE patients...and to hold off for mild PEs.
But those in the middle are trickier. "Submassive" PE patients have systolic BP above 90 mmHg but right ventricular dysfunction on CT or echo...or elevated troponins or BNP.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber Insights: APRN includes:
- Cutting-edge advice about new medications and how they fit into practice
- Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
- Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations
Already a subscriber? Log in
Volume pricing available. Get a quote